Is the clinical outcome of bladder cancer patients with variant histology different from that of patients who develop variant histology during follow-up?

Basit Öğe Kaydı
dc.contributor.authorTuran, T.
dc.contributor.authorBozkurt, Y. E.
dc.contributor.authorAhmadzada, J.
dc.contributor.authorEfiloglu, O.
dc.contributor.authorIplikci, A.
dc.contributor.authorNuroglu, M. T.
dc.contributor.authorYildirim, A.
dc.date.accessioned2025-11-16T19:35:05Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.issn0302-2838
dc.identifier.issn1873-7560
dc.identifier.urihttps://hdl.handle.net/20.500.14730/15535
dc.identifier.volume87
dc.identifier.wosWOS:001578797300006
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Urology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleIs the clinical outcome of bladder cancer patients with variant histology different from that of patients who develop variant histology during follow-up?
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu